ClinicalTrials.gg
Not yet recruitingNCT06797323WaPRUINUpdated Jan 28, 2025

Evaluating the Feasibility of a Web-App for Pelvic Floor Health in Pregnant Women in the Ferrol Health Area: the WaPRUIN Study

An observational study in Pregnancy and Pelvic Floor Disorder, sponsored by Universidad de Oviedo. Not yet recruiting at 1 site in Spain. Open to female participants. Per ClinicalTrials.gov, last updated 2025-01-28.

Sponsored by Universidad de Oviedo · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
212
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Pelvic Floor Disorders with a site in Spain — 9 open to participants now, 10 under way, none of them phase 3. Pelvic Floor Disorders · Spain.

Started
2025
with 2 others
Observational
3 of 29
2 open now
Registered
24th of 29
by date

Among the 29 studies in Pelvic Floor Disorders with a site in Spain, this one is one of 3 that started in 2025, is one of 3 observational ones, and was the 24th registered.

Pelvic Floor Disorders

212 studies on the registry are indexed under Pelvic Floor Disorders; 46 are open to participants now.

Browse Pelvic Floor Disorders studies →

Open to participants now

9 of the 29 studies in Pelvic Floor Disorders with a site in Spain are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 27 Pelvic Floor Disorders studies recruiting now, 17 (63%) set no upper age limit and 10 (37%) stop at 75 or younger; none take children under 18; 9 take healthy volunteers.

This study: female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Pelvic Floor Disorders with a site in Spain, or all of them as a file.
02

Study summary

This study aims to evaluate the feasibility of using a web-based application to improve pelvic floor health in pregnant women within the Ferrol Health Area, Spain. The intervention involves providing educational resources through a user-friendly digital platform, designed to empower women with knowledge about pelvic floor function and techniques for strengthening it during pregnancy.

The study hypothesizes that a web-based educational tool can effectively increase awareness, engagement, and adherence to pelvic floor exercises among pregnant women, thereby contributing to improved maternal health outcomes. Participants will include pregnant women from the Ferrol Health Area, who will voluntarily use the application during their pregnancy.

The study will assess outcomes related to usability, accessibility, and participant satisfaction with the application, as well as any improvements in pelvic floor-related health indicators. By addressing an important gap in maternal health education, this project has the potential to provide an innovative and scalable solution to enhance prenatal care.

03

Conditions studied

  • Pregnancy
  • Pelvic Floor Disorder
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of pregnant women from the Ferrol Health Area who receive prenatal care in the Gynecology and Obstetrics Department at Hospital Arquitecto Marcide.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women attending their first prenatal consultation at the Hospital Arquitecto Marcide.
  • Pregnant women who voluntarily consent to participate in the study by signing the form.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women who do not have proficiency in the Spanish language.
  • Limitations in using the web-app (e.g., physical, cognitive, or technological barriers).
  • Lack of internet access.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
212 participants (estimated)
Patient registry
No

Groups and cohorts

  • Pregnant women

    Behavioral: Web-Based Application for Pelvic Floor Health

Interventions

  • BehavioralWeb-Based Application for Pelvic Floor Health

    A user-friendly web application designed to provide educational resources, exercises, and interactive tools aimed at improving pelvic floor health in pregnant women.

06

What researchers measure

Primary outcomes

  1. Feasibility of the Web-App Usage

    To evaluate the feasibility and usability of the "PelviEduca" web-app, which is designed to improve knowledge about pelvic floor health and related conditions during pregnancy in pregnant women within the Ferrol Health Area.

    Time frame: From enrollment to the end of web application use at 8 weeks

Secondary outcomes

  1. Frequency of Web-App Use

    To analyze the frequency of use of the web-app by the participants during the study.

    Time frame: From enrollment to the end of web application use at 8 weeks

  2. Relationship Between Usability and Participant Characteristics

    To describe the relationship between the feasibility and usability of the web-app and the personal characteristics of the participants.

    Time frame: From enrollment to the end of web application use at 8 weeks

  3. Knowledge Improvement on Pelvic Floor Health

    To evaluate whether the use of the web-app contributes to an increase in knowledge regarding pelvic floor health during pregnancy among participants.

    Time frame: From enrollment to the end of web application use at 8 weeks

  4. Effectiveness in Encouraging Pelvic Floor Exercises

    To determine the effectiveness of the web-app in promoting the practice of pelvic floor exercises among participants.

    Time frame: From enrollment to the end of web application use at 8 weeks

  5. Prevalence of Urinary Incontinence at Inclusion

    To describe the percentage of pregnant women presenting urinary incontinence at the time of enrolment in the study

    Time frame: At baseline (time of enrollment)

07

Study locations

1 site
  • Arquitecto Marcide Hospital
    Ferrol, A Coruña 15405, Spain
08

References and documents

Individual participant data

Plan to share: Undecided — The decision on whether to share individual participant data (IPD) will be made after the completion of the study and analysis of results. Further updates will be provided when available.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2025; primary completion for Nov 2025, 8 months later.

Of 26 observational studies under Pelvic Floor Disorders, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 45. This study's planned 8 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 22, 2025
First posted
Jan 28, 2025
StartEst.
Mar 10, 2025
Primary completionEst.
Nov 2025
CompletionEst.
Nov 2025
Last update
Jan 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06797323
Lead sponsor
Universidad de Oviedo
Responsible party
Raquel Iglesias Méndez (PhD candidate, Universidad de Oviedo) — Principal investigator
First posted
Jan 28, 2025
Start date
Mar 10, 2025 (estimated)
Primary completion
Nov 2025 (estimated)
Completion
Nov 2025 (estimated)
Last update
Jan 28, 2025

Study contacts

Raquel Iglesias-Méndez
Contact
medicinaraquel@gmail.com
+34 626754452

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion